How many studies have been conducted on Bremelanotide?

BiohacksAI has indexed 36 PubMed studies on Bremelanotide, including 14 randomized controlled trials (RCTs). 72% of studies involve human subjects.

What are the main research areas for Bremelanotide?

The primary research domains for Bremelanotide are 😴 Sleep, ♀♂ Sexual Health, 🧬 Hormones. This is based on analysis of 36 PubMed studies using the BiohacksAI evidence platform.

Bremelanotide

a synthetic peptide analogue of alpha-MSH, is an agonist at melanocortin receptors including the MC3R and MC4R, which are expressed primarily in the central nervous system;

36+ PubMed studies analyzed · 14 RCTs · Evidence Score: 55.3

Research Domains

Bremelanotide has been studied across 10 research domains including 😴 Sleep, ♀♂ Sexual Health, 🧬 Hormones, 🧠 Focus & Attention, ❤️ Cardiovascular. The primary research focus is 😴 Sleep with 86% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Bremelanotide, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Loading evidence profile...

This evidence profile for Bremelanotide is generated deterministically from 36 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.